Reliability and Validity of the Turkish Version of the Stroke Exercise Preference Inventory

April 7, 2025 updated by: Halime ARIKAN, Tokat Gaziosmanpasa University
With this study, it will be proven whether the Turkish version of the Stroke Exercise Preference Inventory is valid and reliable in evaluating the exercise preferences of individuals who have had a stroke.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Version, validity, and reliability studies are frequently encountered in the literature. However, there is no scale that evaluates the exercise preferences of individuals who have had a stroke among the measurement tools whose Turkish version, validity, and reliability studies have been carried out. The Stroke Exercise Preference Inventory is an outcome scale for questioning exercise preferences in individuals who have had a stroke. It is functional for the development and planning of exercise programs for individuals who have had a stroke. This scale will both fill the gap in the Turkish literature in terms of the parameters it evaluates and will be the first in this context. In terms of its application, it is a useful inventory in this field. Considering the absence of a measurement tool developed in Turkish or adapted to Turkish for the assessment of exercise preferences of individuals with stroke, the aim of this study is to evaluate the validity and reliability of the Turkish version of the self-administered Stroke Exercise Preference Inventory, designed to question exercise preferences in Turkish individuals with stroke, to perform cross-cultural adaptation study, and to question the suitability of the Turkish version for Turkish society and the effectiveness of its clinical use.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
90

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey
      • Kırıkkale, Turkey, 71300
        • Kırıkkale University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Who have had a stroke,
  • Good cognitive status,
  • Can speak, read, write Turkish.

Exclusion Criteria:

  • Pregnant,
  • Who cannot speak, read or write Turkish.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Other: Individuals who have had a stroke
To evaluate the validity and reliability of the Stroke Exercise Preference Inventory
Other: Reliability and validity study
To evaluate the validity and reliability of the Stroke Exercise Preference Inventory

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Exercise preference
Time Frame: through study completion, an average of 6 month
The Stroke Exercise Preference Inventory was developed in 2016 as an inventory consisting of 13 items. The inventory also includes 9 items that assess exercise barriers. The Stroke Exercise Preference Inventory is very useful and beneficial for clinicians in terms of determining the exercise preferences of individuals who have had a stroke and questioning the thoughts of the individual in continuing the exercise and rehabilitation program. It is functional for the development and planning of exercise programs for individuals who have had a stroke. Inventory scores as a percentage. And the decreasing score indicates the negativity of participation and view of the exercise.
through study completion, an average of 6 month
Cognitive status
Time Frame: through study completion, an average of 6 month
The Mini Mental Test will be used to quantitatively assess cognitive performance. It consists of eleven items gathered under five main headings as orientation, recording memory, attention and calculation, recall and language, and is evaluated out of a total score of 30. A minimum of 24 points must be obtained.
through study completion, an average of 6 month
Functional ambulation
Time Frame: through study completion, an average of 6 month
The Functional Ambulation Classification will be used for the evaluation of ambulation in individuals. The Functional Ambulation Classification shows the support surfaces that walking patients receive. It is valuable when starting to step and walk from the immobility period. It is calculated over a total of 6 categories by scoring between 0 and 5.
through study completion, an average of 6 month
Activity status
Time Frame: through study completion, an average of 6 month
The Frenchay Activities Index is a 15-item index that was created to collect information about daily and social activities, questioning what activities and how often they do in stroke patients. While the first 10 items ask individuals to estimate the frequency of household chores such as preparing meals and washing clothes in the last 3 months, the next 5 items ask them to indicate the frequency of social activities such as travel and gardening in the last six months. Response scores range from 0 (never) to 3 (at least 1 per week). The total scoring range is between 0 (no participation) and 45 (frequent participation).
through study completion, an average of 6 month
Stroke-specific quality of life
Time Frame: through study completion, an average of 6 month
The Stroke-Specific Quality of Life Scale consists of 49 items and 12 domains to assess the quality of life of individuals diagnosed with stroke. These areas are; mobility (6 items), energy (3 items), upper extremity function (5 items), work production (3 items), temperament (5 items), self-care (5 items), social role (5 items), family role ( 3 items), vision (3 items), language (5 items), thinking (3 items) and personality traits (3 items). The items were graded with a Likert-type scoring ranging from 1 to 5. Rating was made as 1. Strongly agree, 2. Partially agree, 3. Undecided, 4. Partially disagree, 5. Strongly disagree. A high scale score indicates a high quality of life, and a low scale score indicates a low quality of life.
through study completion, an average of 6 month
Exercise benefits and barriers
Time Frame: through study completion, an average of 6 month
The Benefits / Barriers of Exercise Scale consists of 24 items, 2 open-ended questions and six sub-dimensions. While 12 of the 24 items of the scale consist of statements about the benefits of exercise, the other 12 are made up of statements that prevent exercise. Negative items are coded in reverse. The scale is evaluated with a 4-point Likert scale. It is scored as 4 (Strongly Agree), 3 (Agree), 2 (Disagree), and 1 (Strongly Disagree). The scale is evaluated over the total score (min=24, max= 96). Higher scores indicate a perception of greater exercise benefits and less exercise barriers.
through study completion, an average of 6 month
Exercise behaviour
Time Frame: through study completion, an average of 6 month
Behavioral Regulations in Exercise Scale-2 consists of 19 items and five subscales. These are: external regulation, introjective regulation, identification regulation, internal regulation and amotivation subscales. The Behavioral Regulations in Exercise Scale-2 is a 5-point Likert-type scale with a score between 0-4, consisting of "not at all true", "sometimes true" and "definitely true". Increasing and decreasing scores according to the sub-scales express positive and negative behavioral thoughts.
through study completion, an average of 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Tokat Gaziosmanpasa University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 1, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 1, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 13, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 18, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 28, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 3, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 8, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 7, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 83116987-272

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Only researchers in the study will have access to individual data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings